Blueprint Medicines Corporation (BPMC)
USD 104.64
(5.43%)
USD 104.64
(5.43%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 774.12 Million USD | 219.29% |
| 2022 | 242.45 Million USD | 117.62% |
| 2021 | 111.4 Million USD | 24.33% |
| 2020 | 89.6 Million USD | -6.61% |
| 2019 | 95.94 Million USD | 556.42% |
| 2018 | 14.61 Million USD | -10.5% |
| 2017 | 16.33 Million USD | 384.6% |
| 2016 | 3.37 Million USD | -14.64% |
| 2015 | 3.94 Million USD | -56.34% |
| 2014 | 9.04 Million USD | 215.82% |
| 2013 | 2.86 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 597.93 Million USD | -22.76% |
| 2024 Q3 | 386.56 Million USD | -36.31% |
| 2024 Q2 | 740.34 Million USD | 23.82% |
| 2023 Q4 | 774.12 Million USD | 515.0% |
| 2023 FY | 774.12 Million USD | 219.29% |
| 2023 Q1 | 118.2 Million USD | -51.24% |
| 2023 Q2 | 116.19 Million USD | -1.7% |
| 2023 Q3 | 125.87 Million USD | 8.33% |
| 2022 Q2 | 107.59 Million USD | -1.76% |
| 2022 Q1 | 109.52 Million USD | -1.69% |
| 2022 Q4 | 242.45 Million USD | -0.62% |
| 2022 Q3 | 243.96 Million USD | 126.74% |
| 2022 FY | 242.45 Million USD | 117.62% |
| 2021 Q1 | 87.67 Million USD | -2.16% |
| 2021 FY | 111.4 Million USD | 24.33% |
| 2021 Q4 | 111.4 Million USD | 32.84% |
| 2021 Q3 | 83.86 Million USD | -2.18% |
| 2021 Q2 | 85.73 Million USD | -2.2% |
| 2020 Q1 | 94.83 Million USD | -1.16% |
| 2020 FY | 89.6 Million USD | -6.61% |
| 2020 Q3 | 91.4 Million USD | -1.86% |
| 2020 Q2 | 93.14 Million USD | -1.79% |
| 2020 Q4 | 89.6 Million USD | -1.97% |
| 2019 Q3 | 97.5 Million USD | -1.51% |
| 2019 FY | 95.94 Million USD | 556.42% |
| 2019 Q4 | 95.94 Million USD | -1.6% |
| 2019 Q2 | 99 Million USD | -0.6% |
| 2019 Q1 | 99.6 Million USD | 581.4% |
| 2018 Q4 | 14.61 Million USD | -4.61% |
| 2018 FY | 14.61 Million USD | -10.5% |
| 2018 Q1 | 17 Million USD | 4.15% |
| 2018 Q2 | 16.16 Million USD | -4.96% |
| 2018 Q3 | 15.32 Million USD | -5.21% |
| 2017 Q4 | 16.33 Million USD | 36.15% |
| 2017 Q3 | 11.99 Million USD | 62.31% |
| 2017 FY | 16.33 Million USD | 384.6% |
| 2017 Q1 | 6.47 Million USD | 92.05% |
| 2017 Q2 | 7.39 Million USD | 14.18% |
| 2016 FY | 3.37 Million USD | -14.64% |
| 2016 Q3 | 8.4 Million USD | -10.27% |
| 2016 Q4 | 3.37 Million USD | -59.89% |
| 2016 Q2 | 9.36 Million USD | -9.28% |
| 2016 Q1 | 10.32 Million USD | 161.45% |
| 2015 Q4 | 3.94 Million USD | -67.0% |
| 2015 FY | 3.94 Million USD | -56.34% |
| 2015 Q2 | 12.49 Million USD | 44.46% |
| 2015 Q1 | 8.65 Million USD | -4.31% |
| 2015 Q3 | 11.96 Million USD | -4.28% |
| 2014 FY | 9.04 Million USD | 215.82% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q4 | 9.04 Million USD | 0.0% |
| 2013 FY | 2.86 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -545056.338% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -10009.467% |
| XOMA Corporation | 124.45 Million USD | -522.035% |
| Mesoblast Limited | 118.92 Million USD | -550.944% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -237.763% |
| Aptorum Group Limited | 3.36 Million USD | -22922.921% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -59483.78% |
| HilleVax, Inc. | 51.19 Million USD | -1412.164% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -2991.295% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -3606.73% |
| Precision BioSciences, Inc. | 31.26 Million USD | -2375.764% |
| Dyadic International, Inc. | 136.92 Thousand USD | -565245.544% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -489850.633% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -26854.109% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -14091.054% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -361639.252% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -14054.727% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -237.408% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -6130.86% |
| IGM Biosciences, Inc. | 40.5 Million USD | -1811.129% |
| Opthea Limited | 200.62 Million USD | -285.848% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -1395.166% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -14235.593% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -7788.739% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -12456.723% |
| NextCure, Inc. | 6.6 Million USD | -11620.242% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -124356.313% |
| Ovid Therapeutics Inc. | 46 Million USD | -1582.811% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -3544.814% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -2461.961% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -1147.075% |
| Senti Biosciences, Inc. | 37.66 Million USD | -1955.228% |
| Apollomics, Inc. | 4.66 Million USD | -16508.496% |
| PureTech Health plc | 25.51 Million USD | -2934.345% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -243334.591% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -5865.799% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -814.238% |
| ChromaDex Corporation | 3.27 Million USD | -23522.887% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -643.048% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -1931.603% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 104.77 Million USD | -638.842% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -647.684% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -663.554% |
| Fortress Biotech, Inc. | 88.59 Million USD | -773.806% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -1125.516% |
| Celcuity Inc. | 37.44 Million USD | -1967.287% |
| ContextLogic Inc. | 6 Million USD | -12802.033% |
| GH Research PLC | 343 Thousand USD | -225591.545% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -11702.439% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -2092121.622% |
| ImmuCell Corporation | 11.96 Million USD | -6367.561% |
| Amarin Corporation plc | 8.73 Million USD | -8760.272% |
| TG Therapeutics, Inc. | 110.79 Million USD | -598.698% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -1228.258% |
| Acelyrin, Inc. | 1.19 Million USD | -64734.338% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Seer, Inc. | 28.25 Million USD | -2639.382% |
| Novavax, Inc. | 280.63 Million USD | -175.847% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -456.802% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 86.645% |
| AnaptysBio, Inc. | 17.81 Million USD | -4245.582% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -14243.561% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -5726.599% |
| AbCellera Biologics Inc. | 77.38 Million USD | -900.416% |
| CorMedix Inc. | 667.63 Thousand USD | -115850.404% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -6966.381% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 71.36% |
| Aptose Biosciences Inc. | 1 Million USD | -76560.467% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -8943083.919% |
| Soligenix, Inc. | 3.49 Million USD | -22052.196% |
| Century Therapeutics, Inc. | 48.17 Million USD | -1507.029% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -572.15% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -171709.104% |
| Kura Oncology, Inc. | 17.2 Million USD | -4400.709% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -11109.412% |
| Ardelyx, Inc. | 55.98 Million USD | -1282.805% |
| Ainos, Inc. | 5.96 Million USD | -12880.879% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -737.495% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -35905.674% |
| Prothena Corporation plc | 11.83 Million USD | -6440.955% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -5439.731% |
| Autolus Therapeutics plc | 52.96 Million USD | -1361.518% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -2967.652% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -1750.063% |
| Celularity Inc. | 65.41 Million USD | -1083.365% |
| Rallybio Corporation | 392 Thousand USD | -197380.102% |
| GRI Bio, Inc. | 14 Thousand USD | -5529342.857% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Omeros Corporation | 338.28 Million USD | -128.84% |
| INmune Bio, Inc. | 10.43 Million USD | -7317.093% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -330.958% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -13005.032% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -947649.755% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -93523.707% |
| Humacyte, Inc. | 58.1 Million USD | -1232.258% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -1237.645% |
| Coherus BioSciences, Inc. | 480.84 Million USD | -60.993% |
| Immunocore Holdings plc | 84.03 Million USD | -821.223% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -41676.686% |
| Verastem, Inc. | 41.55 Million USD | -1762.796% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -6707.263% |
| Histogen Inc. | 4.62 Million USD | -16648.637% |
| Surrozen, Inc. | 3.37 Million USD | -22809.796% |
| Organovo Holdings, Inc. | 1.39 Million USD | -55432.425% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| IO Biotech, Inc. | 2.49 Million USD | -30939.374% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| GT Biopharma, Inc. | 58 Thousand USD | -1334593.103% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -815.168% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -370257.86% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -15326.903% |
| Summit Therapeutics Inc. | 106.09 Million USD | -629.622% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -601.464% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -476819.854% |
| Turnstone Biologics Corp. | 3.21 Million USD | -23985.937% |
| Pulmatrix, Inc. | 8.75 Million USD | -8741.046% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -313309.717% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -693.101% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -5489.329% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -571.13% |
| Cytokinetics, Incorporated | 755.77 Million USD | -2.428% |
| Exelixis, Inc. | 189.94 Million USD | -307.553% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -2428.654% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -597.86% |
| Evogene Ltd. | 1.13 Million USD | -67924.78% |
| Replimune Group, Inc. | 75.86 Million USD | -920.34% |
| PDS Biotechnology Corporation | 23.85 Million USD | -3145.575% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -1403184.691% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -27686.145% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -963601.325% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -1583943.38% |
| BioLineRx Ltd. | 11.59 Million USD | -6578.647% |
| Avid Bioservices, Inc. | 207.83 Million USD | -272.471% |
| Insmed Incorporated | 1.2 Billion USD | 35.704% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -36415.189% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -1591.22% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -1190856.923% |
| MediWound Ltd. | 6.71 Million USD | -11435.121% |
| MiMedx Group, Inc. | 48.09 Million USD | -1509.435% |
| OmniAb, Inc. | 25.56 Million USD | -2928.528% |
| Alector, Inc. | 38.91 Million USD | -1889.11% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -261.847% |
| PTC Therapeutics, Inc. | 415.02 Million USD | -86.524% |
| Mereo BioPharma Group plc | 5.95 Million USD | -12906.082% |
| Zai Lab Limited | 15.15 Million USD | -5009.379% |
| Revance Therapeutics, Inc. | 478.43 Million USD | -61.803% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -47246.911% |
| Aura Biosciences, Inc. | 19.55 Million USD | -3858.286% |
| Immunic, Inc. | 1.33 Million USD | -57930.135% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -2723.717% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -2339.563% |
| Veracyte, Inc. | 12.63 Million USD | -6029.232% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | -20.044% |
| FibroGen, Inc. | 170.45 Million USD | -354.15% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -8424.634% |
| Allakos Inc. | 41.46 Million USD | -1766.929% |
| scPharmaceuticals Inc. | 40.26 Million USD | -1822.377% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -7053.886% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -512563.576% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | 1.63 Million USD | -47283.253% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -379537.195% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -18170.522% |
| Precigen, Inc. | 7.09 Million USD | -10807.736% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 53.866% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -10479.773% |
| Incyte Corporation | 38.28 Million USD | -1921.893% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -257327.988% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -1693.319% |
| XBiotech Inc. | - USD | -Infinity% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -6850.278% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -27686.145% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 238.63 Million USD | -224.4% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -2872.476% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -221711.461% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -2779.811% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -1617.485% |
| Agenus Inc. | 350.24 Million USD | -121.022% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -724116.258% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -54454.052% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -1611.296% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -1693.236% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -1505.097% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -472020.61% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 8.789% |
| UroGen Pharma Ltd. | 100.21 Million USD | -672.469% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -75247.82% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -323.598% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -5453767.831% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -253710.492% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -197379.094% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -11225.852% |
| Chimerix, Inc. | 2.14 Million USD | -36006.437% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -79460.329% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -2077.236% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -448216.761% |
| Pluri Inc. | 29.61 Million USD | -2514.217% |
| Cue Biopharma, Inc. | 14.69 Million USD | -5167.928% |
| MeiraGTx Holdings plc | 89.26 Million USD | -767.228% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -3625764.169% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -15772.914% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -1152.26% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -643.662% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -11091.586% |
| NLS Pharmaceutics AG | 1.63 Million USD | -47283.253% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -2353.791% |
| Nutriband Inc. | 241.28 Thousand USD | -320733.04% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -14059.905% |
| Vor Biopharma Inc. | 35.66 Million USD | -2070.841% |
| Roivant Sciences Ltd. | 499.74 Million USD | -54.902% |
| ProKidney Corp. | 4.41 Million USD | -17441.854% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -63042.088% |
| Daré Bioscience, Inc. | 5.31 Million USD | -14456.241% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 55.506% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -136912.743% |
| Bicycle Therapeutics plc | 44.95 Million USD | -1621.955% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -1889.008% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -978.059% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -780.244% |
| Atai Life Sciences N.V. | 16.47 Million USD | -4598.483% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -31483.976% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -114584.741% |
| MediciNova, Inc. | 215.92 Thousand USD | -358412.639% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -30926.934% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -61288.169% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -67745.925% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -315.364% |
| Biomea Fusion, Inc. | 10.29 Million USD | -7418.667% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 55.85 Million USD | -1285.85% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -21463.287% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -8350.191% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -5176.546% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -6215.239% |
| bluebird bio, Inc. | 330.32 Million USD | -134.351% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -6090.005% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Imunon, Inc. | 1.62 Million USD | -47546.663% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 31.728% |
| BioAtla, Inc. | 2.46 Million USD | -31368.374% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -713.829% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -13858.204% |
| DBV Technologies S.A. | 14.38 Million USD | -5282.95% |
| Fortress Biotech, Inc. | 88.59 Million USD | -773.806% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -7757.511% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -3988.745% |
| aTyr Pharma, Inc. | 15.09 Million USD | -5028.334% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -3577.889% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -237002.174% |
| Galecto, Inc. | 249 Thousand USD | -310792.369% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -47341.94% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 48.366% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -629.863% |
| Entera Bio Ltd. | 390 Thousand USD | -198392.821% |
| Travere Therapeutics, Inc. | 404.78 Million USD | -91.243% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -12369.749% |
| Xencor, Inc. | 83.43 Million USD | -827.826% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -45787.493% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -16695.878% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -63133.586% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -8131.838% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -472020.61% |
| Portage Biotech Inc. | 47 Thousand USD | -1646968.085% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -61288.169% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -31928.217% |
| OncoCyte Corporation | 2.86 Million USD | -26882.293% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -514082.287% |
| Purple Biotech Ltd. | 351 Thousand USD | -220447.578% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -24405.286% |
| Onconetix, Inc. | 9.88 Million USD | -7730.668% |
| MacroGenics, Inc. | 33.97 Million USD | -2178.773% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -37959.114% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -14698.738% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 13.63 Million USD | -5578.295% |
| Aditxt, Inc. | 18.21 Million USD | -4149.218% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -2795.213% |
| Curis, Inc. | 2.79 Million USD | -27606.586% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -36134.05% |
| Adagene Inc. | 22.3 Million USD | -3370.33% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -4526.872% |
| BeiGene, Ltd. | 930.18 Million USD | 16.778% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -268.382% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -95659.535% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | -26.704% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| SciSparc Ltd. | 76 Thousand USD | -1018481.579% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -30840.128% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -843.858% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -275.941% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -16569.294% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 71.143% |
| ADMA Biologics, Inc. | 141.41 Million USD | -447.4% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -1177.872% |
| Clene Inc. | 32.16 Million USD | -2307.021% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -30353.265% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -4006.095% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -35167.517% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -1427.712% |
| Adicet Bio, Inc. | 20.92 Million USD | -3599.685% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -300.701% |
| Absci Corporation | 15.95 Million USD | -4751.3% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -4958.629% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -3714.724% |
| Surrozen, Inc. | 3.37 Million USD | -22809.796% |
| Generation Bio Co. | 97.89 Million USD | -690.776% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -235195.441% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -2716.525% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -2960.013% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -3054.274% |
| Invivyd, Inc. | 2.16 Million USD | -35656.212% |
| Cingulate Inc. | 3.13 Million USD | -24592.107% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -1347.877% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -21968722.81% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -154445.291% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -13865.759% |
| Jaguar Health, Inc. | 35.86 Million USD | -2058.734% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -1228665.079% |
| 2seventy bio, Inc. | 256.67 Million USD | -201.599% |
| Clearside Biomedical, Inc. | 43 Million USD | -1700.242% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -128278.441% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -1253.242% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -13693.67% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -160758.191% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -2638.123% |
| Innoviva, Inc. | 449.07 Million USD | -72.381% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -3728.686% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -1034.577% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -4401.494% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -521.585% |
| Evaxion Biotech A/S | 10.86 Million USD | -7021.848% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -828.326% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -933.444% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -11816.903% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -1888002.439% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -2768.181% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -166377.849% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| AlloVir, Inc. | 27.42 Million USD | -2722.276% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -7479.771% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -21663.34% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -49682.765% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -61338.254% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -5259.471% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -85343.929% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -1396.524% |
| ImmunityBio, Inc. | 883.67 Million USD | 12.398% |
| Korro Bio, Inc. | 33.2 Million USD | -2231.201% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -990.681% |
| Kineta, Inc. | 1.31 Million USD | -58679.195% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -330056.821% |
| BioVie Inc. | 6.11 Million USD | -12566.755% |
| Codexis, Inc. | 22.36 Million USD | -3361.465% |
| Celularity Inc. | 65.41 Million USD | -1083.365% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -202020.627% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -345027.954% |
| Kodiak Sciences Inc. | 181.63 Million USD | -326.204% |
| Cibus, Inc. | 24.62 Million USD | -3044.153% |
| Annexon, Inc. | 31.35 Million USD | -2368.895% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -32953.886% |
| Moderna, Inc. | - USD | -Infinity% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 46.742% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -931.667% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -19734.025% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Eyenovia, Inc. | 16.1 Million USD | -4705.895% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -594.342% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -1581.448% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -2310.243% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -78491.066% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -6656.76% |
| Alkermes plc | 290.73 Million USD | -166.268% |
| Arcellx, Inc. | 97.62 Million USD | -692.955% |
| Moolec Science SA | 2.64 Million USD | -29164.175% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -35922.429% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -12162.348% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -2819.783% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -24855.577% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -32128.226% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -44569.475% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Humacyte, Inc. | 58.1 Million USD | -1232.258% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -2617.457% |
| Geron Corporation | 85.89 Million USD | -801.2% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -1600.993% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Royalty Pharma plc | 6.13 Billion USD | 87.382% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -671566.059% |
| Notable Labs, Ltd. | 2.04 Million USD | -37680.478% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -2188.271% |
| Structure Therapeutics Inc. | 5.45 Million USD | -14096.256% |
| IN8bio, Inc. | 4.89 Million USD | -15721.01% |
| 89bio, Inc. | 27.1 Million USD | -2755.696% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -193430.5% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -1341.353% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -30631.322% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -57756.652% |
| Liquidia Corporation | 3.5 Million USD | -21998.83% |
| Mustang Bio, Inc. | 2.49 Million USD | -30889.672% |
| Immunovant, Inc. | 138 Thousand USD | -560857.971% |
| Vericel Corporation | 88.14 Million USD | -778.257% |
| Quantum-Si incorporated | 15.3 Million USD | -4958.629% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -8776.528% |
| XOMA Corporation | 124.45 Million USD | -522.035% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -282426.277% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -947649.755% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -5730.988% |
| Vaxcyte, Inc. | 29.22 Million USD | -2548.926% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -7000.083% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -381240.887% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -3646.779% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -46731.337% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -61338.254% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -191989.826% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -74911.822% |
| PepGen Inc. | 20.1 Million USD | -3750.587% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -134764.46% |
| United Therapeutics Corporation | 700 Million USD | -10.589% |
| Solid Biosciences Inc. | 26.26 Million USD | -2847.352% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -78491.066% |
| Immuneering Corporation | 4.46 Million USD | -17245.488% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -766357.426% |
| Belite Bio, Inc | 886 Thousand USD | -87272.686% |
| Pharming Group N.V. | 171.54 Million USD | -351.265% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 239.61 Million USD | -223.065% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -3529.094% |
| uniQure N.V. | 138.4 Million USD | -459.3% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -4499.655% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -806.222% |
| Altimmune, Inc. | 671 Thousand USD | -115268.405% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -5730.988% |
| Peak Bio, Inc. | 10.72 Million USD | -7120.07% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -8424.634% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -44211.505% |
| Benitec Biopharma Inc. | 284 Thousand USD | -272478.169% |
| Zura Bio Limited | - USD | -Infinity% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | -73.937% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -267167.636% |
| Compugen Ltd. | 1.35 Million USD | -57199.926% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -367673.138% |
| argenx SE | 20 Million USD | -3770.61% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -1710.134% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -815.525% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -3785.96% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -560.553% |
| PolyPid Ltd. | 11.77 Million USD | -6472.052% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -746.423% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -18415.236% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -132228.547% |
| Instil Bio, Inc. | 86.05 Million USD | -799.577% |
| Elevation Oncology, Inc. | 30.13 Million USD | -2468.676% |
| Immunome, Inc. | 1.65 Million USD | -46816.485% |
| Verona Pharma plc | 51.32 Million USD | -1408.157% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -7816.977% |
| Shattuck Labs, Inc. | 4.2 Million USD | -18322.703% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -213745.856% |
| Design Therapeutics, Inc. | 3.05 Million USD | -25281.049% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -295366.412% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -5340.835% |
| Achilles Therapeutics plc | 4.61 Million USD | -16674.041% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | -107.139% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -2471.919% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -20834.29% |
| Beam Therapeutics Inc. | 173.17 Million USD | -347.022% |
| Moolec Science SA | 2.64 Million USD | -29164.175% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -162873.053% |
| AEON Biopharma, Inc. | 278 Thousand USD | -278361.151% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -10921.099% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -230981.194% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -920.434% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -1166.83% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -2462.534% |
| Athira Pharma, Inc. | 1.58 Million USD | -48740.505% |
| HCW Biologics Inc. | 6.45 Million USD | -11898.586% |
| XOMA Corporation | 124.45 Million USD | -522.035% |
| NeurAxis, Inc. | 224.26 Thousand USD | -345089.512% |
| Lumos Pharma, Inc. | 6.58 Million USD | -11655.839% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -7816.977% |
| 180 Life Sciences Corp. | 1.32 Million USD | -58542.541% |
| Nektar Therapeutics | 230.4 Million USD | -235.989% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -3785.96% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -4432.298% |
| Arvinas, Inc. | 3.4 Million USD | -22668.294% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -49682.765% |
| Palisade Bio, Inc. | 369 Thousand USD | -209689.16% |
| Nutriband Inc. | 241.28 Thousand USD | -320733.04% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -47341.94% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -93619.37% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -186435.422% |
| Merus N.V. | 12.16 Million USD | -6265.088% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -502.767% |
| Neurogene Inc. | 16.25 Million USD | -4662.362% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | -151.222% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -2612.316% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -5503.895% |
| Rezolute, Inc. | 2.22 Million USD | -34645.153% |
| Clene Inc. | 32.16 Million USD | -2307.021% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -442121.499% |
| BeyondSpring Inc. | 3.99 Million USD | -19277.272% |
| Synlogic, Inc. | 17.27 Million USD | -4381.169% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -59447.846% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -2211677.143% |
| Peak Bio, Inc. | 10.72 Million USD | -7120.07% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -1390.904% |
| Krystal Biotech, Inc. | 8.09 Million USD | -9464.147% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -337.318% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -10869.562% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -566632.067% |
| MannKind Corporation | 382.37 Million USD | -102.449% |
| Ikena Oncology, Inc. | 10.73 Million USD | -7109.182% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -189171.883% |
| Gossamer Bio, Inc. | 212.46 Million USD | -264.354% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -444797.701% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -8350.191% |
| Legend Biotech Corporation | 328.67 Million USD | -135.53% |
| Mural Oncology plc | 15 Million USD | -5057.719% |
| Disc Medicine, Inc. | 2.1 Million USD | -36745.407% |
| Champions Oncology, Inc. | 7.43 Million USD | -10318.869% |
| REGENXBIO Inc. | 89.29 Million USD | -766.975% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -90472.682% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -139890.452% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -14198.522% |
| Vaxart, Inc. | 26.51 Million USD | -2819.673% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -4844.141% |
| Cellectis S.A. | 92.85 Million USD | -733.707% |
| Longeveron Inc. | 2.04 Million USD | -37828.564% |
| Repare Therapeutics Inc. | 3.41 Million USD | -22601.525% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 44.579% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -1561.491% |
| Revolution Medicines, Inc. | 87.94 Million USD | -780.244% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -447369.364% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -19483.152% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -244102.524% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -442255.429% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 4.24% |
| Denali Therapeutics Inc. | 52.24 Million USD | -1381.828% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -5273.809% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -56240.757% |
| Cingulate Inc. | 3.13 Million USD | -24592.107% |
| Passage Bio, Inc. | 26.29 Million USD | -2844.101% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -11514.734% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -189635.784% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -86490.828% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -3665.002% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -31482.366% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -24687.768% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -95352.774% |
| OmniAb, Inc. | 25.56 Million USD | -2928.528% |
| Anew Medical, Inc. | 1.6 Million USD | -48131.9% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -2516.792% |
| Lipocine Inc. | 17.16 Thousand USD | -4509523.675% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -6551.676% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -2135.538% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -13005.032% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -1253.999% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -381240.887% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -14887.841% |
| Ocugen, Inc. | 6.94 Million USD | -11052.889% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -5378.958% |
| Q32 Bio Inc. | 1.31 Million USD | -58634.598% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -115096.726% |
| Alumis Inc. Common Stock | 32.58 Million USD | -2276.065% |
| Equillium, Inc. | 824 Thousand USD | -93846.845% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -8426.512% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -257249.255% |
| Dominari Holdings Inc. | 3.02 Million USD | -25465.456% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -819189.426% |
| vTv Therapeutics Inc. | 529 Thousand USD | -146236.862% |
| Bio-Techne Corporation | 419.53 Million USD | -84.518% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -975.229% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -299.927% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -4483.858% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -3300.94% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -12678.508% |
| Nkarta, Inc. | 88.33 Million USD | -776.308% |
| BioCardia, Inc. | 1.31 Million USD | -58768.593% |
| Iterum Therapeutics plc | 19.5 Million USD | -3868.025% |